Keywords
Last Name
Institution

GARY CRAIG CHAMNESS

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Hematology & Oncology
AddressOne Baylor Plaza
HOUSTON TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentBreast Center
    DivisionBreast Cancer Center


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Xu X, De Angelis C, Burke KA, Nardone A, Hu H, Qin L, Veeraraghavan J, Sethunath V, Heiser LM, Wang NJ, Ng CKY, Chen E, Renwick A, Wang T, Nanda S, Shea M, Mitchell T, Rajendran M, Waters I, Zabransky DJ, Scott KL, Gutierrez C, Nagi C, Geyer FC, Chamness GC, Park BH, Shaw C, Hilsenbeck SG, Rimawi MF, Gray JW, Weigelt B, Reis-Filho JS, Osborne CK, Schiff R. HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer. Clin Cancer Res. 2017 May 09. PMID: 28487443.
      View in: PubMed
    2. Giuliano M, Hu H, Wang YC, Fu X, Nardone A, Herrera S, Mao S, Contreras A, Gutierrez C, Wang T, Hilsenbeck SG, De Angelis C, Wang NJ, Heiser LM, Gray JW, Lopez-Tarruella S, Pavlick AC, Trivedi MV, Chamness GC, Chang JC, Osborne CK, Rimawi MF, Schiff R. Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy. Clin Cancer Res. 2015 May 26. PMID: 26015514.
      View in: PubMed
    3. Suo J, Medina D, Herrera S, Zheng ZY, Jin L, Chamness GC, Contreras A, Gutierrez C, Hilsenbeck S, Umar A, Foekens JA, Hanash S, Schiff R, Zhang XH, Chang EC. Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cells. Cell Biosci. 2015; 5:10. PMID: 25774287; PMCID: PMC4359526.
    4. Veeraraghavan J, Tan Y, Cao XX, Kim JA, Wang X, Chamness GC, Maiti SN, Cooper LJ, Edwards DP, Contreras A, Hilsenbeck SG, Chang EC, Schiff R, Wang XS. Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers. Nat Commun. 2014; 5:4577. PMID: 25099679; PMCID: PMC4130357.
    5. Wang YC, Morrison G, Gillihan R, Guo J, Ward RM, Fu X, Botero MF, Healy NA, Hilsenbeck SG, Phillips GL, Chamness GC, Rimawi MF, Osborne CK, Schiff R. Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation. Breast Cancer Res. 2011; 13(6):R121. PMID: 22123186; PMCID: PMC3326563.
    6. Bu W, Chen J, Morrison GD, Huang S, Creighton CJ, Huang J, Chamness GC, Hilsenbeck SG, Roop DR, Leavitt AD, Li Y. Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer. Oncogene. 2011 Oct 27; 30(43):4399-409. PMID: 21532625; PMCID: PMC3156856.
    7. Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR, Tsimelzon A, Wang T, Hilsenbeck SG, Chamness GC, Andò S, Fuqua SA. Loss of Rho GDI? and resistance to tamoxifen via effects on estrogen receptor ?. J Natl Cancer Inst. 2011 Apr 6; 103(7):538-52. PMID: 21447808; PMCID: PMC3071355.
    8. Dave B, Migliaccio I, Gutierrez MC, Wu MF, Chamness GC, Wong H, Narasanna A, Chakrabarty A, Hilsenbeck SG, Huang J, Rimawi M, Schiff R, Arteaga C, Osborne CK, Chang JC. Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers. J Clin Oncol. 2011 Jan 10; 29(2):166-73. PMID: 21135276; PMCID: PMC3058274.
    9. Rodriguez AA, Makris A, Wu MF, Rimawi M, Froehlich A, Dave B, Hilsenbeck SG, Chamness GC, Lewis MT, Dobrolecki LE, Jain D, Sahoo S, Osborne CK, Chang JC. DNA repair signature is associated with anthracycline response in triple negative breast cancer patients. Breast Cancer Res Treat. 2010 Aug; 123(1):189-96. PMID: 20582464.
      View in: PubMed
    10. Rimawi MF, Shetty PB, Weiss HL, Schiff R, Osborne CK, Chamness GC, Elledge RM. Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes. Cancer. 2010 Mar 1; 116(5):1234-42. PMID: 20082448; PMCID: PMC2829330.
    11. De Amicis F, Thirugnansampanthan J, Cui Y, Selever J, Beyer A, Parra I, Weigel NL, Herynk MH, Tsimelzon A, Lewis MT, Chamness GC, Hilsenbeck SG, Andò S, Fuqua SA. Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. 2010 May; 121(1):1-11. PMID: 19533338; PMCID: PMC2995248.
    12. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008 May 7; 100(9):672-9. PMID: 18445819.
      View in: PubMed
    13. Creighton CJ, Kent Osborne C, van de Vijver MJ, Foekens JA, Klijn JG, Horlings HM, Nuyten D, Wang Y, Zhang Y, Chamness GC, Hilsenbeck SG, Lee AV, Schiff R. Molecular profiles of progesterone receptor loss in human breast tumors. Breast Cancer Res Treat. 2009 Mar; 114(2):287-99. PMID: 18425577; PMCID: PMC2635926.
    14. Chang JC, Makris A, Gutierrez MC, Hilsenbeck SG, Hackett JR, Jeong J, Liu ML, Baker J, Clark-Langone K, Baehner FL, Sexton K, Mohsin S, Gray T, Alvarez L, Chamness GC, Osborne CK, Shak S. Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. Breast Cancer Res Treat. 2008 Mar; 108(2):233-40. PMID: 17468949.
      View in: PubMed
    15. Tham YL, Gomez LF, Mohsin S, Gutierrez MC, Weiss H, Hilsenbeck SG, Elledge RM, Chamness GC, Osborne CK, Allred DC, Chang JC. Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers. Breast Cancer Res Treat. 2005 Dec; 94(3):279-84. PMID: 16261403.
      View in: PubMed
    16. Zhang X, Podsypanina K, Huang S, Mohsin SK, Chamness GC, Hatsell S, Cowin P, Schiff R, Li Y. Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations. Oncogene. 2005 Jun 16; 24(26):4220-31. PMID: 15824740.
      View in: PubMed
    17. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Tham YL, Kalidas M, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, Lewis MT, Wong H, O'Connell P. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. J Clin Oncol. 2005 Feb 20; 23(6):1169-77. PMID: 15718313.
      View in: PubMed
    18. Mohsin SK, Weiss HL, Gutierrez MC, Chamness GC, Schiff R, Digiovanna MP, Wang CX, Hilsenbeck SG, Osborne CK, Allred DC, Elledge R, Chang JC. Neoadjuvant trastuzumab induces apoptosis in primary breast cancers. J Clin Oncol. 2005 Apr 10; 23(11):2460-8. PMID: 15710948.
      View in: PubMed
    19. Lee AV, Chamness G, Oesterreich S. 26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational research. Breast Cancer Res. 2004; 6(2):E10. PMID: 14979916; PMCID: PMC400657.
    20. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, O'Connell P. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet. 2003 Aug 2; 362(9381):362-9. PMID: 12907009.
      View in: PubMed
    21. Schiff R, Chamness GC, Brown PH. Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs). Breast Cancer Res. 2003; 5(5):228-31. PMID: 12927029; PMCID: PMC314430.
    22. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM, Schiff R. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst. 2003 Mar 5; 95(5):353-61. PMID: 12618500.
      View in: PubMed
    23. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003 Feb 1; 97(3):545-53. PMID: 12548595.
      View in: PubMed
    24. Schiff R, Reddy P, Ahotupa M, Coronado-Heinsohn E, Grim M, Hilsenbeck SG, Lawrence R, Deneke S, Herrera R, Chamness GC, Fuqua SA, Brown PH, Osborne CK. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Natl Cancer Inst. 2000 Dec 6; 92(23):1926-34. PMID: 11106684.
      View in: PubMed
    25. Zellars RC, Hilsenbeck SG, Clark GM, Allred DC, Herman TS, Chamness GC, Elledge RM. Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients. J Clin Oncol. 2000 May; 18(9):1906-13. PMID: 10784631.
      View in: PubMed
    26. Hilsenbeck SG, Ravdin PM, de Moor CA, Chamness GC, Osborne CK, Clark GM. Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat. 1998; 52(1-3):227-37. PMID: 10066085.
      View in: PubMed
    27. Clark GM, Allred DC, Hilsenbeck SG, Chamness GC, Osborne CK, Jones D, Lee WH. Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer. Cancer Res. 1997 Dec 15; 57(24):5505-8. PMID: 9407959.
      View in: PubMed
    28. Oesterreich S, Hilsenbeck SG, Ciocca DR, Allred DC, Clark GM, Chamness GC, Osborne CK, Fuqua SA. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients. Clin Cancer Res. 1996 Jul; 2(7):1199-206. PMID: 9816288.
      View in: PubMed
    29. Ravdin PM, Chamness GC. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review. Gene. 1995 Jun 14; 159(1):19-27. PMID: 7607568.
      View in: PubMed
    30. Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM. Rising levels of estrogen receptor in breast cancer over 2 decades. Cancer. 1994 Sep 1; 74(5):1601-6. PMID: 8062191.
      View in: PubMed
    31. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994 May 4; 86(9):705-12. PMID: 7908990.
      View in: PubMed
    32. Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol. 1994 Mar; 12(3):467-74. PMID: 8120545.
      View in: PubMed
    33. Osborne CK, Chamness GC. Translational research in the San Antonio breast cancer SPORE. Breast Cancer Res Treat. 1994; 32(1):1-4. PMID: 7819578.
      View in: PubMed
    34. Fuqua SA, Benedix MG, Krieg S, Weng CN, Chamness GC, Oesterreich S. Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells. Breast Cancer Res Treat. 1994; 32(2):177-86. PMID: 7865847.
      View in: PubMed
    35. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst. 1993 Oct 6; 85(19):1558-70. PMID: 8411230.
      View in: PubMed
    36. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993 Feb 3; 85(3):200-6. PMID: 8423624.
      View in: PubMed
    37. Fuqua SA, Chamness GC, McGuire WL. Estrogen receptor mutations in breast cancer. J Cell Biochem. 1993 Feb; 51(2):135-9. PMID: 8440747.
      View in: PubMed
    38. Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chamness GC, Gullick WJ, McGuire WL. Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques. Anticancer Res. 1992 Nov-Dec; 12(6B):1965-71. PMID: 1363511.
      View in: PubMed
    39. McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM. Prognosis and treatment decisions in patients with breast cancer without axillary node involvement. Cancer. 1992 Sep 15; 70(6 Suppl):1775-81. PMID: 1355403.
      View in: PubMed
    40. McGuire WL, Chamness GC, Fuqua SA. Abnormal estrogen receptor in clinical breast cancer. J Steroid Biochem Mol Biol. 1992 Sep; 43(1-3):243-7. PMID: 1525064.
      View in: PubMed
    41. McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM. Treatment decisions in axillary node-negative breast cancer patients. J Natl Cancer Inst Monogr. 1992; (11):173-80. PMID: 1627425.
      View in: PubMed
    42. McGuire WL, Chamness GC, Fuqua SA. Abnormal oestrogen receptor in clinical breast cancer. Eur J Cancer. 1992; 28(2-3):309-10. PMID: 1591044.
      View in: PubMed
    43. McGuire WL, Chamness GC, Fuqua SA. The importance of normal and abnormal oestrogen receptor in breast cancer. Cancer Surv. 1992; 14:31-40. PMID: 1423328.
      View in: PubMed
    44. McGuire WL, Chamness GC, Fuqua SA. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol. 1991 Nov; 5(11):1571-7. PMID: 1779964.
      View in: PubMed
    45. Fuqua SA, Hill SM, Chamness GC, Benedix MG, Greene GL, O'Malley BW, McGuire WL. Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors. J Natl Cancer Inst. 1991 Aug 21; 83(16):1157-60. PMID: 1679459.
      View in: PubMed
    46. Salman M, Reddy BR, Delgado P, Stotter PL, Fulcher LC, Chamness GC. 17 alpha-substituted analogs of estradiol for the development of fluorescent estrogen receptor ligands. Steroids. 1991 Jul; 56(7):375-87. PMID: 1780954.
      View in: PubMed
    47. Salman M, Chamness GC. A potential radioiodinated ligand for androgen receptor: 7 alpha-methyl-17 alpha-(2'-(E)-iodovinyl)-19-nortestosterone. J Med Chem. 1991 Mar; 34(3):1019-24. PMID: 2002446.
      View in: PubMed
    48. Fuqua SA, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 1991 Jan 1; 51(1):105-9. PMID: 1988075.
      View in: PubMed
    49. Falette NS, Fuqua SA, Chamness GC, Cheah MS, Greene GL, McGuire WL. Estrogen receptor gene methylation in human breast tumors. Cancer Res. 1990 Jul 1; 50(13):3974-8. PMID: 2354445.
      View in: PubMed
    50. McGuire WL, Tandon AK, Allred DC, Chamness GC, Clark GM. How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst. 1990 Jun 20; 82(12):1006-15. PMID: 2189998.
      View in: PubMed
    51. Tandon AK, Clark GM, Chamness GC, McGuire WL. Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer. Cancer Res. 1990 Jun 1; 50(11):3317-21. PMID: 2334924.
      View in: PubMed
    52. Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL. Cathepsin D and prognosis in breast cancer. N Engl J Med. 1990 Feb 1; 322(5):297-302. PMID: 2296271.
      View in: PubMed
    53. Chamness GC. Progestin action and progesterone receptors in breast cancer. Cancer Res. 1989 Dec 15; 49(24 Pt 1):7176-9. PMID: 2582458.
      View in: PubMed
    54. Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL. HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol. 1989 Aug; 7(8):1120-8. PMID: 2569032.
      View in: PubMed
    55. Salman M, Stotter PL, Chamness GC. 125I-ligand for progesterone receptor: 17 alpha-(6'-iodohex-1'-ynyl)-19-nortestosterone. J Steroid Biochem. 1989 Jul; 33(1):25-31. PMID: 2761264.
      View in: PubMed
    56. Hill SM, Fuqua SA, Chamness GC, Greene GL, McGuire WL. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res. 1989 Jan 1; 49(1):145-8. PMID: 2562795.
      View in: PubMed
    57. Díaz-Chico BN, Ogasawara Y, Chamness GC, Salman M, McGuire WL. A 46-kDa antigen associated with estrogen receptor in human breast cancer. J Steroid Biochem. 1988; 30(1-6):315-20. PMID: 3386260.
      View in: PubMed
    58. Hanauske AR, Osborne CK, Chamness GC, Clark GM, Forseth BJ, Buchok JB, Arteaga CL, Von Hoff DD. Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents. Eur J Cancer Clin Oncol. 1987 May; 23(5):545-51. PMID: 3498632.
      View in: PubMed
    59. Salman M, Ruiz AA, Stotter PL, Chamness GC. A progesterone receptor affinity chromatography reagent: 17 alpha-hexynyl nortestosterone sepharose. J Steroid Biochem. 1987 Mar; 26(3):383-91. PMID: 3586653.
      View in: PubMed
    60. Tandon AK, Chamness GC, McGuire WL. Direct counting of tritium by dissolving Microelisa wells in scintillation fluid. J Immunol Methods. 1986 Sep 27; 92(2):281-3. PMID: 3760588.
      View in: PubMed
    61. Tandon AK, Chamness GC, McGuire WL. Estrogen receptor in very small breast tumor specimens: a modified charcoal-gelatin assay. Cancer Res. 1986 Jul; 46(7):3375-7. PMID: 3708571.
      View in: PubMed
    62. Tandon AK, Chamness GC, McGuire WL. Progesterone receptor assays in low-protein cytosols: a modified charcoal-gelatin procedure. J Steroid Biochem. 1986 Jun; 24(6):1135-40. PMID: 2426518.
      View in: PubMed
    63. Ray S, Salman M, Ruiz AA, Stotter PL, Chamness GC. Androgen receptor affinity chromatography: synthesis and properties of 17 alpha-epoxypropyl-dihydrotestosterone Sepharose. J Steroid Biochem. 1986 Jun; 24(6):1111-5. PMID: 3736037.
      View in: PubMed
    64. Salman M, Reddy BR, Ray S, Stotter PL, Chamness GC. 17 alpha-allyl estradiol analogues as candidates for development of high-affinity fluorescein-estradiol conjugates. J Steroid Biochem. 1986 Feb; 24(2):539-48. PMID: 3702438.
      View in: PubMed
    65. Gross GE, Clark GM, Chamness GC, McGuire WL. Multiple progesterone receptor assays in human breast cancer. Cancer Res. 1984 Feb; 44(2):836-40. PMID: 6692382.
      View in: PubMed
    66. Ciocca DR, Adams DJ, Bjercke RJ, Sledge GW, Edwards DP, Chamness GC, McGuire WL. Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity. J Histochem Cytochem. 1983 May; 31(5):691-6. PMID: 6341459.
      View in: PubMed
    67. Carrillo AJ, Steger RW, Chamness GC. Dopaminergic stimulation of pituitary but not hypothalamic estrogen receptors in ovariectomized rats. Endocrinology. 1983 May; 112(5):1839-46. PMID: 6131816.
      View in: PubMed
    68. Amador AG, Bartke A, Parkening TA, Chamness GC. Genetic differences in androgen receptors and in autoregulation of testicular human chorionic gonadotropin binding sites in the mouse. J Recept Res. 1983; 3(4):495-512. PMID: 6417328.
      View in: PubMed
    69. Hull DF, Clark GM, Osborne CK, Chamness GC, Knight WA, McGuire WL. Multiple estrogen receptor assays in human breast cancer. Cancer Res. 1983 Jan; 43(1):413-6. PMID: 6847780.
      View in: PubMed
    70. Chamness GC, McGuire WL. Questions about histochemical methods for steroid receptors. Arch Pathol Lab Med. 1982 Feb; 106(2):53-4. PMID: 6895825.
      View in: PubMed
    71. Mercer WD, Edwards DP, Chamness GC, McGuire WL. Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors. Cancer Res. 1981 Nov; 41(11 Pt 1):4644-52. PMID: 7030480.
      View in: PubMed
    72. Chamness GC, Mercer WD, McGuire WL. Are histochemical methods for estrogen receptor valid? J Histochem Cytochem. 1980 Aug; 28(8):792-8. PMID: 7003005.
      View in: PubMed
    73. Edwards DP, Martin PM, Horwitz KB, Chamness GC, McGuire WL. Subcellular compartmentalization of estrogen receptors in human breast cancer cells. Exp Cell Res. 1980 May; 127(1):197-213. PMID: 7379864.
      View in: PubMed
    74. Chamness GC, Asch RH, Pauerstein CJ. Danazol binding and translocation of steroid receptors. Am J Obstet Gynecol. 1980 Feb 15; 136(4):426-9. PMID: 7355922.
      View in: PubMed
    75. Edwards DP, Chamness GC, McGuire WL. Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta. 1979 Dec 19; 560(4):457-86. PMID: 391286.
      View in: PubMed
    76. Chamness GC, Bannayan GA, Landry LA, Sheridan PJ, McGuire WL. Abnormal reproductive development in rats after neonatally administered antiestrogen (tamoxifen). Biol Reprod. 1979 Dec; 21(5):1087-90. PMID: 574777.
      View in: PubMed
    77. Powell B, Garola RE, Chamness GC, McGuire WL. Measurement of progesterone receptor in human breast cancer biopsies. Cancer Res. 1979 May; 39(5):1678-82. PMID: 427805.
      View in: PubMed
    78. Chamness GC, King TW, Sheridan PJ. Androgen receptor in the rat brain--assays and properties. Brain Res. 1979 Feb 2; 161(2):267-76. PMID: 758974.
      View in: PubMed
    79. McGuire WL, Zava DT, Horwitz KB, Garola RE, Chamness GC. Receptors and breast cancer: do we know it all? J Steroid Biochem. 1978 May; 9(5):461-6. PMID: 682638.
      View in: PubMed
    80. McGuire WL, Horwitz KB, Zava DT, Garola RE, Chamness GC. Hormones in breast cancer: update 1978. Metabolism. 1978 Apr; 27(4):487-501. PMID: 345042.
      View in: PubMed
    81. McGuire WL, Zava DT, Horwitz KB, Chamness GC. Steroid receptors in breast tumors--current status. Curr Top Exp Endocrinol. 1978; 3:93-129. PMID: 350504.
      View in: PubMed
    82. Chamness GC, Zava DT, McGuire WL. Methods for assessing the binding of steroid hormones in nuclei. Methods Cell Biol. 1978; 17:325-38. PMID: 212668.
      View in: PubMed
    83. Koseki Y, Zava DT, Chamness GC, McGuire WL. Estrogen receptor translocation and replenishment by the antiestrogen tamoxifen. Endocrinology. 1977 Oct; 101(4):1104-10. PMID: 561688.
      View in: PubMed
    84. Koseki Y, Zava DT, Chamness GC, McGuire WL. Progesterone interaction with estrogen and antiestrogen in the rat uterus--receptor effects. Steroids. 1977 Aug; 30(2):169-77. PMID: 201053.
      View in: PubMed
    85. Zava DT, Chamness GC, Horwitz KB, McGuire WL. Human breast cancer: biologically active estrogen receptor in the absence of estrogen? Science. 1977 May 6; 196(4290):663-4. PMID: 193182.
      View in: PubMed
    86. McGuire WL, De La Garza M, Chamness GC. Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res. 1977 Mar; 37(3):637-9. PMID: 837364.
      View in: PubMed
    87. McGuire WL, Chamness GC, Horwitz KB, Zava DT. Prolactin and estrogen receptors in breast cancer. Pathobiol Annu. 1977; 7:191-211. PMID: 201904.
      View in: PubMed
    88. McGuire WL, Horwitz KB, Chamness GC, Zava DT. A physiological role for estrogen and progesterone in breast cancer. J Steroid Biochem. 1976 Nov-Dec; 7(11-12):875-82. PMID: 799735.
      View in: PubMed
    89. Chamness GC, McGuire WL. Scatchard plots: common errors in correction and interpretation. Steroids. 1975 Oct; 26(4):538-42. PMID: 173047.
      View in: PubMed
    90. Chamness GC, Costlow ME, McGuire WL. Estrogen receptor in rat liver and its dependence on prolactin. Steroids. 1975 Sep; 26(3):363-71. PMID: 173045.
      View in: PubMed
    91. McGuire WL, Chamness GC, Costlow ME, Richert NJ. Steroids and human breast cancer. J Steroid Biochem. 1975 May; 6(5):723-7. PMID: 171510.
      View in: PubMed
    92. Chamness GC, Huff K, McGuire WL. Protamine-precipitated estrogen receptor: a solid-phase ligand exchange assay. Steroids. 1975 May; 25(5):627-35. PMID: 167479.
      View in: PubMed
    93. Chamness GC, McGuire WL. Extraction artifacts in the preparation of estrogen receptor. Methods Enzymol. 1975; 36:176-87. PMID: 162978.
      View in: PubMed
    94. Chamness GC, Jennings AW, McGuire WL. Estrogen receptor binding to isolated nuclei. A nonsaturable process. Biochemistry. 1974 Jan 15; 13(2):327-31. PMID: 4358942.
      View in: PubMed
    95. McGuire WL, Chamness GC, Costlow ME, Shepherd RE. Hormone dependence in breast cancer. Metabolism. 1974 Jan; 23(1):75-100. PMID: 4357247.
      View in: PubMed
    96. McGuire WL, DeLaGarza M, Chamness GC. Estrogen receptor in a prolactin secreting pituitary tumor (MtTW5). Endocrinology. 1973 Oct; 93(4):810-3. PMID: 4353853.
      View in: PubMed
    97. Chamness GC, Jennings AW, McGuire WL. Oestrogen receptor binding is not restricted to target nuclei. Nature. 1973 Feb 16; 241(5390):458-60. PMID: 4350283.
      View in: PubMed
    98. McGuire WL, Chamness GC. Studies on the estrogen receptor in breast cancer. Adv Exp Med Biol. 1973; 36(0):113-36. PMID: 4369235.
      View in: PubMed
    99. McGuire WL, Huff K, Chamness GC. Temperature-dependent binding of estrogen receptor to chromatin. Biochemistry. 1972 Nov 21; 11(24):4562-5. PMID: 4347385.
      View in: PubMed
    100. Chamness GC, McGuire WL. Estrogen receptor in the rat uterus. Physiological forms and artifacts. Biochemistry. 1972 Jun 20; 11(13):2466-72. PMID: 5040652.
      View in: PubMed
    101. McGuire WL, Huff K, Jenning A, Chamness GC. Mammary carcinoma: a specific biochemical defect in autonomous tumors. Science. 1972 Jan 21; 175(4019):335-6. PMID: 5008163.
      View in: PubMed
    102. McGuire WL, Julian JA, Chamness GC. A dissociation between ovarian dependent growth and estrogen sensitivity in mammary carcinoma. Endocrinology. 1971 Oct; 89(4):969-73. PMID: 5092660.
      View in: PubMed
    103. Chamness GC, Willson CD. An unusual lac repressor mutant. J Mol Biol. 1970 Nov 14; 53(3):561-5. PMID: 4924012.
      View in: PubMed
    CHAMNESS's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _